The role of skeletal scanning in clinical oncology.
- 9 August 1980
- Vol. 281 (6237) , 407-410
- https://doi.org/10.1136/bmj.281.6237.407
Abstract
No abstract availableThis publication has 57 references indexed in Scilit:
- Radionuclide Scanning in Patients with Advanced Malignant MelanomaClinical Nuclear Medicine, 1979
- Rationale for the use of bone scans in selected metastatic and primary bone tumorsSeminars in Nuclear Medicine, 1978
- A Clinical Comparison of 99mTc-Hydroxyethylidene Diphosphonate (H.E.D.P.) and 99mTc-Pyrophosphate in the Detection of Bone MetastasesClinical Nuclear Medicine, 1977
- Contribution of the Bone Scan, Serum Acid and Alkaline Phosphatase, and the Radiographic Bone Survey to the Management of Newly- Diagnosed Carcinoma of the ProstateClinical Nuclear Medicine, 1977
- Serial Bone Scanning Using Technetium 99m Diphosphonate in Patients Undergoing Cyclical Combination Chemotherapy for Advanced Breast CancerClinical Nuclear Medicine, 1976
- Paget's disease of boneSeminars in Nuclear Medicine, 1976
- Bone trauma and related benign disease: Assessment by bone scanningSeminars in Nuclear Medicine, 1976
- Skeletal Metastases in Pancreatic Carcinoma: Study by Isotopic Bone ScanningOncology, 1976
- BONE SCANNING—OSTEOGENIC SARCOMAAmerican Journal of Roentgenology, 1975
- Occult bone metastasesBritish Journal of Surgery, 1948